ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Aimmune Therapeutics, Inc.

Loading...
Loading...

Rowley Law PLLC is investigating potential securities law violations by Aimmune Therapeutics, Inc. AIMT and its board of directors concerning the proposed acquisition of the company by Nestlé S.A. Stockholders will receive $34.50 in cash for each share of Aimmune Therapeutics stock that they hold. The transaction is valued at approximately $2.6 billion and is expected to close in the fourth quarter of 2020.

If you are a stockholder of Aimmune Therapeutics, Inc. and are interested in obtaining additional information regarding this investigation, please visit us at: http://www.rowleylawpllc.com/investigation/aimt/. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at info@rowleylawpllc.com, or by telephone at 914-400-1920 or 844-400-4643 (toll-free).

Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit http://www.rowleylawpllc.com.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...